Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.
Kelly O’Brien shared how the COVID-19 pandemic isn’t hurting Obliteride participation.
South Seattle Emerald covered the region’s important role in testing potential COVID vaccines.
Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more.
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
GeekWire mentioned Fred Hutch’s planned expansion into the Steam Plant.
Michele Andrasik spoke about the priorities of CoVPN and the COVID-19 vaccine trials.
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
Stephaun Wallace spoke about the barriers to clinical trial enrollment in Black, Latino and other minority populations, and the strategies to encourage those populations to participate in clinical trials.
Ruth Etzioni weighed in on how family interactions can be a large source of COVID-19 spread to at risk populations.
Michele Andrasik discussed how outreach methods may need to differ depending on the communities that researchers are trying to reach with COVID-19 trials.
Dr. Matthias Stephan talked about his methodology to deliver immune cells to tumors with thin metal mesh, which won Health Innovation of the Year in the 2020 GeekWire awards.
Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development.
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
Stephaun Wallace discussed the details of the CoVPN clinical trials and the focuses of the program.
Trevor Bedford’s work and comments on COVID-19 from the beginning of the pandemic are referenced.
KING 5 described how Fred Hutch’s Obliteride is changing formats in response to the COVID-19 pandemic.
Trevor Bedford discussed his work with Nextstrain and the start of tracking COVID-19 in Seattle.
Anne McTiernan provided information on ways to reduce breast cancer risk, including reducing alcohol intake.
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
Forbes covered the CoVPN program, its goals and how the network will be run.
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
Dr. Ryan Cassaday spoke about alternative to CAR T-cell therapies and the benefits of other treatments.
Stephaun Wallace provided information about the CoVPN network, specifically the call for diverse applicants across ethnic, racial, occupational groups and ages.
Dr. Jim Kublin explained the CoVPN network, and the goals of the program.
Dr. Rachel Issaka discussed her recent essay on structural racism in academic medicine, and what should be done to change it.
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Tyler Starr commented on the possibility of a SARS-CoV-2 mutation causing the virus to be more infectious.
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
Research from Fred Hutch indicating the COVID-19 infection rate in Washington is increasing above peak levels from March is referenced.
Susan Bullman commented on an outside study suggesting certain microbial signatures in blood are associated with cancer.
Julie Czartoski discussed testing the Everett’ Fire Station as part of the COVID cohort study.
Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.
Julie Czartoski explained the goals of the COVID cohort study and the value of enrolling first responders like firefighters.
Trevor Bedford discussed his work on SARS-CoV-2 genomic epidemiology using twitter for science outreach and communications.
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
The CoVPN announcement is covered by KING 5.
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.